Trial · NCT00433966
Participant flow44
How many started, completed or left each group, period by period.
1 to 20 of 44
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Pharmacology Intervention/Randomization | STARTED | Pharmacology Arm - Bivalirudin | 1,800 | |
| Pharmacology Intervention/Randomization | STARTED | Pharmacology Arm - Unfractionated Heparin | 1,802 | |
| Pharmacology Intervention/Randomization | STARTED | Stent Arm - Paclitaxel-Eluting Stent | 0 | |
| Pharmacology Intervention/Randomization | STARTED | Stent Arm - Bare Metal Stent | 0 | |
| Pharmacology Intervention/Randomization | 30-Day Follow-up | Pharmacology Arm - Bivalirudin | 1,787 | |
| Pharmacology Intervention/Randomization | 30-Day Follow-up | Pharmacology Arm - Unfractionated Heparin | 1,791 | |
| Pharmacology Intervention/Randomization | 30-Day Follow-up | Stent Arm - Paclitaxel-Eluting Stent | 0 | |
| Pharmacology Intervention/Randomization | 30-Day Follow-up | Stent Arm - Bare Metal Stent | 0 | |
| Pharmacology Intervention/Randomization | 1-Year Follow-up | Pharmacology Arm - Bivalirudin | 1,696 | |
| Pharmacology Intervention/Randomization | 1-Year Follow-up | Pharmacology Arm - Unfractionated Heparin | 1,702 | |
| Pharmacology Intervention/Randomization | 1-Year Follow-up | Stent Arm - Paclitaxel-Eluting Stent | 0 | |
| Pharmacology Intervention/Randomization | 1-Year Follow-up | Stent Arm - Bare Metal Stent | 0 | |
| Pharmacology Intervention/Randomization | 3-Year Follow-up | Pharmacology Arm - Bivalirudin | 1,634 | |
| Pharmacology Intervention/Randomization | 3-Year Follow-up | Pharmacology Arm - Unfractionated Heparin | 1,628 | |
| Pharmacology Intervention/Randomization | 3-Year Follow-up | Stent Arm - Paclitaxel-Eluting Stent | 0 | |
| Pharmacology Intervention/Randomization | 3-Year Follow-up | Stent Arm - Bare Metal Stent | 0 | |
| Pharmacology Intervention/Randomization | COMPLETED | Pharmacology Arm - Bivalirudin | 1,634 | |
| Pharmacology Intervention/Randomization | COMPLETED | Pharmacology Arm - Unfractionated Heparin | 1,628 | |
| Pharmacology Intervention/Randomization | COMPLETED | Stent Arm - Paclitaxel-Eluting Stent | 0 | |
| Pharmacology Intervention/Randomization | COMPLETED | Stent Arm - Bare Metal Stent | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00433966/flow